Cargando…
TLRs in COVID-19: How they drive immunopathology and the rationale for modulation
COVID-19 is both a viral illness and a disease of immunopathology. Proximal events within the innate immune system drive the balance between deleterious inflammation and viral clearance. We hypothesize that a divergence between the generation of excessive inflammation through over activation of the...
Autores principales: | Mabrey, F. Linzee, Morrell, Eric D, Wurfel, Mark M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762091/ https://www.ncbi.nlm.nih.gov/pubmed/34806446 http://dx.doi.org/10.1177/17534259211051364 |
Ejemplares similares
-
Presence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus-2 on Admission Is Associated With Decreased Mortality in COVID-19 Critical Illness
por: Mabrey, F. Linzee, et al.
Publicado: (2022) -
Plasma Interleukin-6 Predicts Clinical Decline After Completion of Dexamethasone Therapy in Severe COVID-19
por: Mabrey, F. Linzee, et al.
Publicado: (2022) -
Plasma Soluble CD14 Subtype Levels Are Associated With Clinical Outcomes in Critically Ill Subjects With Coronavirus Disease 2019
por: Mabrey, F. Linzee, et al.
Publicado: (2021) -
Evaluating construct validity of computable acute respiratory distress syndrome definitions in adults hospitalized with COVID-19: an electronic health records based approach
por: Sathe, Neha A., et al.
Publicado: (2023) -
Phase 2, randomized, double-blind, placebo-controlled multi-center trial of the clinical and biological effects of anti-CD14 treatment in hospitalized patients with COVID-19 pneumonia
por: Mabrey, F. Linzee, et al.
Publicado: (2023)